ARALEZ PHARMACEUTICALS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
ARALEZ PHARMACEUTICALS INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $4.07 per share as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2018-05-08
- 2018-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $4.07.
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $4.54.
- 2017-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $4.59.
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $5.26.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2018-03-31 | $4.07 10-Q · filed 2018-05-08 |
| 2017-12-31 | $4.54 10-K · filed 2018-03-14 |
| 2017-09-30 | $4.59 10-Q · filed 2017-11-09 |
| 2017-06-30 | $5.26 10-Q · filed 2017-08-09 |
| 2017-03-31 | $5.48 10-Q · filed 2017-05-09 |
| 2016-12-31 | $6.59 10-K · filed 2017-03-13 |